Réaction #77837

ord-34d4fc9cc13c4bdf8beec827c99b7fdd

Solvants

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    LavageThe EtOAc layer was washed with 1 N HCl and brine
  2. 2
    SéchageThe EtOAc was dried (MgSO4)
  3. 3
    Filtrationfiltered
  4. 4
    Concentrationconcentrated
  5. 5
    AutreReverse phase HPLC purification (gradient elution, water/acetonitrile/TFA)

Mode opératoire

2-(amino)-N-[2-[[(cis)-2-[[4-(methylthio)benzoyl]amino]cyclohexyl]amino]-2-oxoethyl]-5-trifluoromethyl benzamide (Example 114a) (50 mg) was dissolved in THF (2.5 mL) prior to the addition of triethylamine (30 mg) and ethyl isocyanate (21 mg). After stirring for 72 h, EtOAc was added along with 1 N HCl solution. The EtOAc layer was washed with 1 N HCl and brine. The EtOAc was dried (MgSO4), filtered, and concentrated. Reverse phase HPLC purification (gradient elution, water/acetonitrile/TFA) provided the title benzamide (10 mg). MS found: (M+Na)+=602.4.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US06706712B2uspto-grants-2004_03